Henan Cancer Hospital
Clinical trials sponsored by Henan Cancer Hospital, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Can a new pill shrink the spleen in myelofibrosis? Results expected Sep 2026 (estimated)
- New shot could shield chemo patients from deadly infections Results expected Oct 2026 (estimated)
- New drug combo shows promise for Hard-to-Treat breast cancer Results expected Dec 2026 (estimated)
- Can a simple blood test predict lung cancer treatment outcomes? Results expected Dec 2026 (estimated)
- Lung cancer drug anlotinib tested in Real-World review after treatment failure Results expected Dec 2026 (estimated)
-
New drug combo shows promise against tough lymphoma
Disease control OngoingThis phase 2 trial tests whether adding the immunotherapy drug camrelizumab to standard chemotherapy (AVD) can improve outcomes for people with advanced classical Hodgkin lymphoma who have not yet been treated. About 60 adults aged 18 to 75 will receive the combination for up to …
Phase 2 • Sponsor: Henan Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Can a new drug shield lung cancer patients from Chemo's worst side effects?
Disease control By invitation onlyThis study tests whether the drug trilaciclib, given before chemotherapy, can prevent bone marrow suppression (low blood cell counts) in people with advanced non-small cell lung cancer. About 40 participants will receive trilaciclib before their platinum-based chemo. The main goa…
Phase 2 • Sponsor: Henan Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Promising cocktail may turn inoperable stomach cancer into surgical candidates
Disease control OngoingThis phase II trial tests a combination of three drugs—fruquintinib, sintilimab, and SOX (S-1 plus oxaliplatin)—as a pre-surgery treatment for people with stage IV gastric cancer that cannot be fully removed. The goal is to shrink the tumor enough to allow complete surgical remov…
Phase 2 • Sponsor: Henan Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC